Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Glycine receptor autoantibodies disrupt inhibitory neurotransmission.

Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM.

Brain. 2019 Oct 8. pii: awz297. doi: 10.1093/brain/awz297. [Epub ahead of print]

PMID:
31591639
2.

Building a Magnetic Resonance Imaging Safety Culture from the Ground Up.

Crisp S, Dawdy K.

J Med Imaging Radiat Sci. 2018 Mar;49(1):18-22. doi: 10.1016/j.jmir.2017.10.005. Epub 2017 Dec 26.

PMID:
30479282
3.

Engineering Carrier Effective Masses in Ultrathin Quantum Wells of IrO_{2}.

Kawasaki JK, Kim CH, Nelson JN, Crisp S, Zollner CJ, Biegenwald E, Heron JT, Fennie CJ, Schlom DG, Shen KM.

Phys Rev Lett. 2018 Oct 26;121(17):176802. doi: 10.1103/PhysRevLett.121.176802.

PMID:
30411938
4.

Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.

Keddie S, Crisp SJ, Blackaby J, Cox A, Coles A, Hart M, Church AJ, Vincent A, Zandi M, Lunn MP.

Eur J Neurol. 2018 Nov;25(11):1384-1388. doi: 10.1111/ene.13759. Epub 2018 Aug 31.

PMID:
30035842
5.

Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.

Hall CE, Yao Z, Choi M, Tyzack GE, Serio A, Luisier R, Harley J, Preza E, Arber C, Crisp SJ, Watson PMD, Kullmann DM, Abramov AY, Wray S, Burley R, Loh SHY, Martins LM, Stevens MM, Luscombe NM, Sibley CR, Lakatos A, Ule J, Gandhi S, Patani R.

Cell Rep. 2017 May 30;19(9):1739-1749. doi: 10.1016/j.celrep.2017.05.024.

6.

Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors.

Crisp SJ, Balint B, Vincent A.

Curr Opin Neurol. 2017 Jun;30(3):310-316. doi: 10.1097/WCO.0000000000000450. Review.

PMID:
28306573
7.

Wilderness adventure therapy effects on the mental health of youth participants.

Bowen DJ, Neill JT, Crisp SJR.

Eval Program Plann. 2016 Oct;58:49-59. doi: 10.1016/j.evalprogplan.2016.05.005. Epub 2016 May 13.

8.

Autoimmune synaptopathies.

Crisp SJ, Kullmann DM, Vincent A.

Nat Rev Neurosci. 2016 Feb;17(2):103-17. doi: 10.1038/nrn.2015.27. Review.

PMID:
26806629
9.

WDR45 Mutation in Atypical Rett Syndrome with Brain Iron Accumulation.

Crisp SJ, Meyer E, Gregory A, Archer H, Hayflick S, Kurian MA, de Silva R.

Mov Disord Clin Pract. 2015 Feb 24;2(1):81-83. doi: 10.1002/mdc3.12120. eCollection 2015 Mar. No abstract available.

10.

β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.

Hayflick SJ, Kruer MC, Gregory A, Haack TB, Kurian MA, Houlden HH, Anderson J, Boddaert N, Sanford L, Harik SI, Dandu VH, Nardocci N, Zorzi G, Dunaway T, Tarnopolsky M, Skinner S, Holden KR, Frucht S, Hanspal E, Schrander-Stumpel C, Mignot C, Héron D, Saunders DE, Kaminska M, Lin JP, Lascelles K, Cuno SM, Meyer E, Garavaglia B, Bhatia K, de Silva R, Crisp S, Lunt P, Carey M, Hardy J, Meitinger T, Prokisch H, Hogarth P.

Brain. 2013 Jun;136(Pt 6):1708-17. doi: 10.1093/brain/awt095. Epub 2013 May 17.

11.

ARF6 directs axon transport and traffic of integrins and regulates axon growth in adult DRG neurons.

Eva R, Crisp S, Marland JR, Norman JC, Kanamarlapudi V, ffrench-Constant C, Fawcett JW.

J Neurosci. 2012 Jul 25;32(30):10352-64.

12.

Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion.

Dash S, Crisp S, Hartnell S, Donald S, Davenport K, Simmons D, Evans M.

Diabetes Res Clin Pract. 2012 Mar;95(3):e49-51. doi: 10.1016/j.diabres.2011.11.008. Epub 2011 Dec 1.

PMID:
22136721
13.

Endogenous patterns of activity are required for the maturation of a motor network.

Crisp SJ, Evers JF, Bate M.

J Neurosci. 2011 Jul 20;31(29):10445-50. doi: 10.1523/JNEUROSCI.0346-11.2011.

14.

Comparison of bifunctional chelates for (64)Cu antibody imaging.

Ferreira CL, Yapp DT, Crisp S, Sutherland BW, Ng SS, Gleave M, Bensimon C, Jurek P, Kiefer GE.

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2117-26. doi: 10.1007/s00259-010-1506-1. Epub 2010 Jun 16.

PMID:
20552190
15.

Carotid atherosclerotic calcification does not result in high signal intensity in MR imaging of intraplaque hemorrhage.

Bitar R, Moody AR, Symons S, Leung G, Crisp S, Kiss A, Nelson A, Maggisano R.

AJNR Am J Neuroradiol. 2010 Sep;31(8):1403-7. doi: 10.3174/ajnr.A2126. Epub 2010 May 13.

16.

The development of motor coordination in Drosophila embryos.

Crisp S, Evers JF, Fiala A, Bate M.

Development. 2008 Nov;135(22):3707-17. doi: 10.1242/dev.026773. Epub 2008 Oct 16.

17.

In vivo 3D high-spatial-resolution MR imaging of intraplaque hemorrhage.

Bitar R, Moody AR, Leung G, Symons S, Crisp S, Butany J, Rowsell C, Kiss A, Nelson A, Maggisano R.

Radiology. 2008 Oct;249(1):259-67. doi: 10.1148/radiol.2491071517.

PMID:
18796681
18.

Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.

Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD.

J Antimicrob Chemother. 2004 Aug;54(2):376-85. Epub 2004 Jun 16.

PMID:
15201233
19.
20.

Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts.

Faulk WP, Rose M, Meroni PL, Del Papa N, Torry RJ, Labarrere CA, Busing K, Crisp SJ, Dunn MJ, Nelson DR.

Hum Immunol. 1999 Sep;60(9):826-32.

PMID:
10527389
21.

A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine.

Jurcevic S, Dunn MJ, Crisp S, Busing K, Rinaldi M, Pellegrini C, Yacoub MH, Vigano M, Banner NL, Rose ML.

Transplantation. 1998 May 15;65(9):1197-202.

PMID:
9603168
22.

Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation.

Cunningham DA, Crisp SJ, Barbir M, Lazem F, Dunn MJ, Yacoub MH.

Eur Heart J. 1998 Feb;19(2):319-25.

PMID:
9519327
23.
24.

Characterization of endothelial antigens associated with transplant-associated coronary artery disease.

Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML.

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 2):S188-97. No abstract available.

PMID:
8719484
25.

A method of two-dimensional mapping of cortical perfusion by cylindrical transformation of HMPAO SPET data.

Ichise M, Crisp S, Ganguli N, Tsai S, Gray BG.

Nucl Med Commun. 1995 May;16(5):386-94.

PMID:
7659391
26.

Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation.

Smith JD, Crisp SJ, Dunn MJ, Pomerance A, Yacoub MH, Rose ML.

Transpl Immunol. 1995 Mar;3(1):68-73.

PMID:
7551982
27.

Detection of proteins on protein blots using chemiluminescent systems.

Crisp SJ, Dunn MJ.

Methods Mol Biol. 1994;32:233-7. Review. No abstract available.

PMID:
7951724
28.

Detection of proteins in polyacrylamide gels using an ultrasensitive silver staining technique.

Dunn MJ, Crisp SJ.

Methods Mol Biol. 1994;32:113-8. Review. No abstract available.

PMID:
7951716
29.

Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease?

Crisp SJ, Dunn MJ, Rose ML, Barbir M, Yacoub MH.

J Heart Lung Transplant. 1994 Jan-Feb;13(1 Pt 1):81-91; discussion 91-2.

PMID:
7909446
30.

Anti-endothelial antibodies and coronary artery disease after cardiac transplantation.

Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH.

Lancet. 1992 Jun 27;339(8809):1566-70.

PMID:
1351550
31.

Low interrater agreement on the semantic base of textual material.

Lee VL, Barnett K, Crisp S, Young L, Bron M, Vatmanidis PC, Atkinson L.

Anal Verbal Behav. 1989;7:91-7.

32.

An evaluation of planned early postnatal transfer home with nursing support.

James ML, Hudson CN, Gebski VJ, Browne LH, Andrews GR, Crisp SE, Palmer D, Beresford JL.

Med J Aust. 1987 Nov 2;147(9):434-5, 437-8.

PMID:
3670194
33.

The prevalence of human isolates of Salmonella subspecies II in southern Africa.

Schrire L, Crisp S, Bear N, McStay G, Koornhof HJ, Le Minor L.

Epidemiol Infect. 1987 Feb;98(1):25-31.

34.

Determination of free boric acid in cosmetic products.

Crisp S, Lyall PK, Pindar AG, Tinsley HM.

Analyst. 1985 Feb;110(2):209-10. No abstract available.

PMID:
3985353
35.
36.

The aqueous erosion of silicophosphate cements.

Wilson AD, Crisp SU, Lewis BG.

J Dent. 1982 Sep;10(3):187-97. No abstract available.

PMID:
6958692
37.

Radioactive tracer technique for monitoring of microleakage: an interim report.

Crisp S, Wilson AD.

J Biomed Mater Res. 1980 Jul;14(4):373-82.

PMID:
6995460
38.

Glass-ionomer cement formulations. II. The synthesis of novel polycarobxylic acids.

Crisp S, Kent BE, Lewis BG, Ferner AJ, Wilson AD.

J Dent Res. 1980 Jun;59(6):1055-63.

PMID:
6929290
39.

Characterization of glass--ionomer cements. 6. A study of erosion and water absorption in both neutral and acidic media.

Crisp S, Lewis BG, Wilson AD.

J Dent. 1980 Mar;8(1):68-74. No abstract available.

PMID:
6929282
40.

Solid sorbent gas samplers.

Crisp S.

Ann Occup Hyg. 1980;23(1):47-76. No abstract available.

PMID:
7377668
41.
42.

Characterization of glass-ionomer cements. 5. The effect of the tartaric acid concentration in the liquid component.

Crisp S, Lewis BG, Wilson AD.

J Dent. 1979 Dec;7(4):304-12. No abstract available.

PMID:
292651
43.

The quantitative measurement of the opacity of aesthetic dental filling materials.

Crisp S, Abel G, Wilson AD.

J Dent Res. 1979 Jun;58(6):1585-96.

PMID:
286705
44.

The hydration of dental cements.

Wilson AD, Paddon JM, Crisp S.

J Dent Res. 1979 Mar;58(3):1065-71.

PMID:
284040
45.

Enteric fever caused by Salmonella paratyphi C in South and South West Africa.

Jacobs MR, Koornhof HJ, Crisp SI, Palmhert HL, Fitzstephens A.

S Afr Med J. 1978 Sep 9;54(11):434-8.

PMID:
104399
46.

A study of temperature changes occurring in setting dental cements.

Crisp S, Jennings MA, Wilson AD.

J Oral Rehabil. 1978 Apr;5(2):139-44.

PMID:
280627
47.

Infrared spectroscopic studies on the development of crystallinity in dental zinc phosphate cements.

Crisp S, O'Neill IK, Prosser HJ, Stuart B, Wilson AD.

J Dent Res. 1978 Feb;57(2):245-54.

PMID:
277520
48.

Characterization of glass-ionomer cements. 4. Effect of molecular weight on physical properties.

Wilson AD, Crisp S, Abel G.

J Dent. 1977 Jun;5(2):117-20. No abstract available.

PMID:
269134
49.

Characterization of glass-ionomer cements. 3. Effect of polyacid concentration on the physical properties.

Crisp S, Lewis BG, Wilson AD.

J Dent. 1977 Mar;5(1):51-6. No abstract available.

PMID:
269128
50.

Experimental luting agents based on the glass ionomer cements.

Wilson AD, Crisp S, Lewis BG, McLean JW.

Br Dent J. 1977 Feb 15;142(4):117-22. No abstract available.

PMID:
264788

Supplemental Content

Support Center